A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M) (NCT07519395)
BALANCE - A Two-part, 26-week, Randomized, Double-Blind, Dose-rAnging, pLAcebo-coNtrolled, Phase 2b Study to Evaluate the effiCacy and safEty of Camlipixant in Adults With IBS-D and IBS-M
🩺 Plain-English Summary (8th-Grade Level)
This study is designed to evaluate the efficacy and safety of camlipixant in adults with IBS-D and IBS-M. The study has two parts. After the first part, some participants will be randomly chosen again to either get a higher dose or stop the drug.
Who can join: Review the eligibility criteria below.
Location: GSK Investigational Site — Anniston, Alabama
Age range: 18 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (110 Sites)
Showing the first 25 of 110 sites.
- GSK Investigational Site — Anniston, Alabama
- GSK Investigational Site — Guntersville, Alabama
- GSK Investigational Site — Mobile, Alabama
- GSK Investigational Site — Saraland, Alabama
- GSK Investigational Site — Scottsdale, Arizona
- GSK Investigational Site — Tempe, Arizona
- GSK Investigational Site — Anaheim, California
- GSK Investigational Site — Chula Vista, California
- GSK Investigational Site — Coronado, California
- GSK Investigational Site — Garden Grove, California
- GSK Investigational Site — Lancaster, California
- GSK Investigational Site — Lancaster, California
- GSK Investigational Site — Los Angeles, California
- GSK Investigational Site — Murrieta, California
- GSK Investigational Site — Pasadena, California
- GSK Investigational Site — San Diego, California
- GSK Investigational Site — San Diego, California
- GSK Investigational Site — Sherman Oaks, California
- GSK Investigational Site — West Hills, California
- GSK Investigational Site — Aurora, Colorado
- GSK Investigational Site — Colorado Springs, Colorado
- GSK Investigational Site — Lone Tree, Colorado
- GSK Investigational Site — Brandon, Florida
- GSK Investigational Site — Clearwater, Florida
- GSK Investigational Site — Coral Gables, Florida
📞 Contact the Study Coordinator
Phone: (877) 379-3718
Email: GSKClinicalSupportHD@gsk.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Irritable Bowel Syndrome
- Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS) — Boston, Massachusetts
- Pilot Study of the Physiological Effects of an Integrative Medicine Approach in Irritable Bowel Syndrome — Philadelphia, Pennsylvania
- A Well-Being Intervention for People With IBS — Madison, Wisconsin
- Standardized Yoga & Meditation Program for Stress Reduction for Adolescents With Irritable Bowel Syndrome — Camden, New Jersey
- Defining Objective Markers of Compliance for Dietary Therapies in IBS — Ann Arbor, Michigan
- Mucosal and Microbiota Changes During Acute Campylobacteriosis — Rochester, Minnesota
Explore by condition: All Irritable Bowel Syndrome clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.